ACA: Sunshine Act to lift shade on payments to doctors from drug, device companies
Practices should prepare now for their providers’ reimbursement arrangements and other affiliations with medical device and drug companies to become public this fall. In particular, you should get ready to answer patients’ questions about those relationships.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.